Deselecting melanoma patients for sentinel lymph node biopsy during COVID-19: clinical utility of tumor molecular profiling. Gallery Deselecting melanoma patients for sentinel lymph node biopsy during COVID-19: clinical utility of tumor molecular profiling. Deselecting melanoma patients for sentinel lymph node biopsy during COVID-19: clinical utility of tumor molecular profiling. Meves & Eggermont 2020. Mayo Clin Proc Inn Qual Out. kari.sharp@gmail.com2025-03-25T03:47:58-05:00October 1, 2020| Read More